Sign in
Taking people in United StatesPhase 2

Comparing two sedation drugs during sleep airway exams in children with sleep apnea

Compares dexmedetomidine and propofol sedation for airway exams in children with obstructive sleep apnea.

Key facts

Who runs it
Erin Kirkham
Where
Ann Arbor, United StatesSee the site
Trial code
Registry title
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
Status
Recruiting
Phase
Phase 2
People taking part
90 people, planned
Started
5 Oct 2022
Expected to end
1 Jan 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Propofol sedation
  • Dexmedetomidine sedation
Record updated
14 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children aged 3 to 11 with obstructive sleep apnea who are planned for surgery to remove the tonsils and adenoids. It compares two sedation drugs during a sleep endoscopy, a camera look at the airway during sleep.

Age
3.00 to 11.99 years at the time of consent
Sex
Boys and girls
Disease stage
Obstructive sleep apnea shown on an overnight sleep lab test in the last 12 months: Obstructive Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5. An ear, nose and throat surgeon plans adenotonsillectomy and thinks sleep endoscopy first would help, because of at least one risk factor for sleep apnea remaining after surgery. Examples: obesity (>95th percentile of body mass index for age), severe apnea (AHI ≥10 events/hour), symptoms that do not fit the exam (eg. small tonsils), African American race, or age ≥7 years.
Earlier treatment
The child cannot have had adenotonsillectomy or other upper airway surgery, including tracheostomy. Removal of the adenoids alone is allowed if it was more than 18 months before recruitment.

Main reasons for not taking part

  • Earlier tonsil and adenoid surgery or other upper airway surgery
  • A major illness that the study could worsen, make risky, or that could affect the results
  • Allergy or other reason not to receive propofol, dexmedetomidine, ketamine or sevoflurane
  • Allergy to eggs, egg products, soybeans or soybean products
  • A reason the child cannot have general anesthesia

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Diagnosed with Obstructive sleep apnea (OSA) by the following criteria: Obstructive Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5, confirmed on nocturnal, laboratory-based polysomnography within the previous 12 months scored using American Academy of Sleep Medicine pediatric criteria in an accredited sleep lab
  • Considered to be a surgical candidate for adenotonsillectomy to treat OSA by an board-certified or board-eligible otolaryngologist
  • Clinical determination by the child's otolaryngologist surgeon that the child would benefit from sleep endoscopy prior to adenotonsillectomy due to one or more reported risk factors for residual sleep apnea after surgery, which may include:; Obese (>95th percentile of body mass index for age); Severe preoperative OSA (AHI ≥10 events/hour); Discordance between awake physical exam (eg. small tonsils) and sleep apnea symptoms or severity; African American race; Age ≥7 years old
  • Male or Female ages 3.00 - 11.99 years of age at the time of consent
  • Parent/guardian ability to understand and willingness to sign a written informed consent
  • Parent/guardian must understand/read/speak English or Spanish and be able and willing to complete questionnaires

Who cannot take part

  • Previous adenotonsillectomy or other upper airway surgery (including tracheostomy) with the exception of isolated adenoidectomy if it occurred >18 months prior to recruitment
  • History of allergic reaction to or contraindication to receiving propofol, dexmedetomidine, ketamine or sevoflurane
  • Contraindication to receiving general anesthesia
  • Allergy to eggs, egg products, soybeans or soybean products
  • Major medical diagnosis that may be exacerbated by the study treatment, pose undue risk to the patient, or that may impact interpretation of study results

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 11 years old?

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Brittany NordhausTaking people

About the trial

What the trial wants to find out

This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persists after adenotonsillectomy, the surgery that removes the tonsils and adenoids.

The 2 groups in the trial

  • Propofol sedationTreatment being tested

    2.5 mg/kg loading dose, then continue at an infusion of 250 mcg/kg/minute.

  • Dexmedetomidine sedationTreatment being tested

    1 mcg/kg loading dose, then continue at an infusion of 1 mcg/kg/hour

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Trial of Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
Plain-language title
Comparing two sedation drugs during sleep airway exams in children with sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05303987, who can take part
Record updated
14 May 2026